COMMUNIQUÉS West-GlobeNewswire

Summit Therapeutics plc : 1st Quarter Results
14/06/2017
Summit Therapeutics plc ('Summit', the 'Company' or the 'Group') SUMMIT THERAPEUTICS REPORTS FINANCIAL RESULTS FOR THE FIRST QUARTER ENDED 30 APRIL 2017 AND OPERATIONAL PROGRESS Oxford, UK, 14 June 2017 - Summit [...]
Medical Prognosis Institute A/S Announces Start of Subscription Period for Rights Issue
14/06/2017
As of today, Tuesday June 14, 2017, subscription opens for a rights issue in Medical Prognosis Institute A/S (MPI). The rights issue is open to the public. Subscription period ends on Thursday June 29, 2017. A fully [...]
argenx presents update on Phase I data from ARGX-110 expansion study in patients with cutaneous T-cell lymphomas at the International Conference of Malignant Lymphoma (ICML)
14/06/2017
June 14, 2017 Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the [...]
Xbrane Biopharma AB (publ) launch a long-term share savings program for employees
14/06/2017
Press release 2017-06-14 Xbrane Biopharma AB (publ) has launched a long-term share savings program for all employees in both Sweden and Italy. The purpose of the program is to create good conditions for retain and [...]
Enzymatica receives record order from STADA Arzneimittel AG
14/06/2017
Press release Lund, June 14, 2017 Enzymatica has received its largest order to date for a total of about SEK 12 million. The global pharmaceutical company STADA Arzneimittel AG ("STADA"), headquartered in Germany, has [...]
Basilea announces distribution agreement with Avir Pharma Inc. for Cresemba® (isavuconazole) and Zevtera® (ceftobiprole) in Canada
14/06/2017
Basel, Switzerland, June 14, 2017 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that Basilea Pharmaceutica International Ltd. (Basilea) has entered into a distribution and license agreement with Avir Pharma [...]
ABLYNX TO PRESENT ADDITIONAL DATA FOR ITS ANTI-IL-6R NANOBODY, VOBARILIZUMAB, AT THE ANNUAL EUROPEAN CONGRESS OF RHEUMATOLOGY
14/06/2017
GHENT, Belgium, 14 June 2017 - Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] announces that it will present additional data from the two Phase IIb studies in rheumatoid arthritis (RA) with its anti-IL-6R Nanobody®, [...]
Targovax ASA: Resolutions to increase the share capital in Targovax ASA in relation to exercise of employee options and settlement of restricted stock units
14/06/2017
The board of directors of Targovax ASA (the "Company") has on 14 June 2017, in accordance with the authorisations granted by the general meeting on 5 April 2017, resolved: - to increase the share capital of up to NOK [...]
Orion Corporation: Managers' transactions - Konsta Westerlund
13/06/2017
ORION CORPORATION MANAGERS' TRANSACTIONS 13 th of JUNE 2017 at 22.15 EEST Orion Corporation: Managers' transactions - Konsta Westerlund Orion Corporation has received the following disclosure under Market Abuse [...]
Orion Corporation: Managers' transactions - Inka Westerlund
13/06/2017
ORION CORPORATION MANAGERS' TRANSACTIONS 13 th of JUNE 2017 at 22.10 EEST Orion Corporation: Managers' transactions - Inka Westerlund Orion Corporation has received the following disclosure under Market Abuse Regulation [...]
Orion Corporation: Managers' transactions - Leevi Westerlund
13/06/2017
ORION CORPORATION MANAGERS' TRANSACTIONS 13 th of JUNE MONTH 2017 at 22.00 EEST Orion Corporation: Managers' transactions - Leevi Westerlund Orion Corporation has received the following disclosure under Market Abuse [...]
Zinpro Corporation Announces Executive Leadership Changes
13/06/2017
Anderson Promotes Scrimgeour to President & CEO, and Sheffer Joins Company as COO EDEN PRAIRIE, Minn., June 13, 2017 (GLOBE NEWSWIRE) -- Zinpro Corporation announces that its owner, Michael D. Anderson, has promoted [...]
Solon Eiendom ASA - Primary insider notification
13/06/2017
SOLON EIENDOM ASA STOCK EXCHANGE ANNOUNCEMENT Solon Eiendom ASA - Primary insider notification (Oslo, Norway, 13 June 2017) Solon Eiendom ASA Chairman of the Board Simen Thorsen (through his wholly owned company [...]
Silmäasema Oyj: Managers' Transactions - Maisa Romanainen
13/06/2017
Silmäasema Oyj - Managers' Transactions Maisa Romanainen 13 June 2017, at 5 p.m. ____________________________________________ Person subject to the notification requirement Name: Romanainen, Maisa Position: Member of [...]
AbCellera Announces Expanded Research Collaboration with Teva
13/06/2017
Collaboration extends initial partnership and aims to generate lead antibody candidates against membrane targets using AbCellera's antibody discovery platform VANCOUVER, British Columbia, June 13, 2017 (GLOBE NEWSWIRE [...]
RedHill Biopharma Initiates Promotion of Donnatal® and EnteraGam® in the U.S.
13/06/2017
RedHill has initiated commercial activities in the U.S. with its gastrointestinal-focused sales force, promoting two gastrointestinal specialty products, Donnatal ® and EnteraGam ® TEL-AVIV, Israel and RALEIGH, N.C., [...]
Novo Nordisk A/S - Share repurchase programme
13/06/2017
Bagsværd, Denmark, 13 June 2017 - On 2 February 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 ( [...]
Midatech Pharma Plc: R&D manufacturing site visit for investors and analysts
13/06/2017
13 June 2017 Midatech Pharma PLC ("Midatech", "Company" or "Group") R&D manufacturing site visit for investors and analysts Midatech Pharma (AIM: MTPH; Nasdaq: MTP), the international specialty pharmaceutical [...]
Summit Therapeutics plc : Notice of Results
13/06/2017
Summit Therapeutics plc ("Summit" or the "Company") SUMMIT THERAPEUTICS TO REPORT FINANCIAL RESULTS FOR THE FIRST QUARTER ENDED 30 APRIL 2017 ON 14 JUNE 2017 Oxford, UK, 13 June 2017 - Summit Therapeutics plc (AIM: SUMM [...]

Pages